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Ganglioside GD2 is a cell surface glycosphingolipid.
Targeting of GD2, i.e., by anti-GD2 mAb 3F8, is
used clinically for cancer diagnosis, prognosis,
and therapy. Here, the conformations of free GD2,
and of GD2 bound to mAb 3F8, were resolved by
saturation transfer difference NMR and molecular
modeling. Then, three small-molecule cyclic peptide
ligands that bind to GD2 selectively were designed.
Transferred nuclear Overhauser enhancement of
the GD2-bound conformation of the peptide ligands
showed an induced-fit binding mechanism. The
mAb 3F8 and the peptidic GD2 ligands mediate
similar biological functions in cell-based assays of
calcium fluxes and src activation. Thus, small mole-
cules can selectively and functionally interact with
a sugar head group. This work furthers the concept
of rationally designing ligands for carbohydrate
targets, andmay be expanded to other clinically rele-
vant gangliosides.
INTRODUCTION
The structures of the glycans protruding from eukaryotic plasma
membranes change with the onset of cancer (Dube and Bertozzi,
2005) and other pathologies. For example, ganglioside GD2
is expressed during embryonic development, and in the adult it
is normally expressed at very low levels in the peripheral nervous
system and the cerebellum (Svennerholm et al., 1994; Yuki et al.,Chemistry & Biology 17, 1831997) but it is overexpressed in neuroblastomas, small-cell lung
carcinomas, and melanomas (Cahan et al., 1982; Watanabe
et al., 1982; Cheresh et al., 1986; Thurin et al., 1986). GD2 is
thus targeted clinically for diagnosis and immunotherapy (Modak
and Cheung, 2007) using anti-GD2 monoclonal antibodies
(mAb), such as IgG3 mAb 3F8. The importance of gangliosides
in tumorigenesis, tumor progression, and tumor metastasis
may be due to their biological functions (Hakomori and Zhang,
1997; Birkle et al., 2003), which include cell recognition, cell
matrix attachment, cell growth, or differentiation, including the
induction of Ca2+ fluxes and the activation of the src family
kinases (Gouy et al., 1994; Golard, 1998; Birkle et al., 2003).
Previously, the interactions of mAbs directed against ganglio-
side GT1a and GD3 were studied by saturation transfer differ-
ence (STD) nuclear magnetic resonance (NMR) spectroscopy
and surface plasmon resonance (SPR) measurements (Houliston
et al., 2007). Also, binding epitopes and conformations were
obtained by STD and 2D NMR in the presence of GM1 micelles
for natural peptides that interact with ganglioside GM1 (enkeph-
alin [Chatterjee et al., 2004], amyloid peptide [Mandal and
Pettegrew, 2004], and bradykinin [Chatterjee and Mukhopad-
hyay, 2005]). However, GD2 has not been studied in this manner;
and more importantly generally the structural data obtained for
carbohydrates have been impervious to the design of selective
ligands with biological activity.
Here we studied whether NMR-based approaches can
generate GD2-selective ligands with biological activity. We report
the use of STD NMR spectroscopy (Meyer and Peters, 2003) to
study the binding characteristics of anti-GD2 mAb 3F8 to two
forms of GD2: (i) intact ganglioside GD2 in dodecylphosphocho-
line (DPC, that form micelles as a plasma membrane mimic), and
(ii) the ‘‘GD2 carbohydrate head’’ as a water-soluble phenyl-
thioether analog of GD2 that lacks ceramide and lipids.–194, February 26, 2010 ª2010 Elsevier Ltd All rights reserved 183
Figure 1. Structures and Antibody Binding of Ganglioside GD2 and
its Derivatives
(A) The carbohydrate ‘‘head’’ of GD2 is shown, to which can be attached either
a ceramide or lipid tail (X1), this is herein referred to as ganglioside GD2. The
ceramide tail of ganglioside GD2 can be truncated (X2) for the purpose of
modeling. X3 is a synthetic water-soluble thiophenyl GD2, lacking the ceram-
ide and lipid tail, as an analog of ganglioside GD2. Residues and torsion angels
are shown (also see Table S3).
(B) Soluble thiophenyl GD2 binds to anti-GD2 mAb 3F8 and therefore
competes 3F8 binding to immobilized ganglioside GD2 in competitive ELISA.
Soluble thiophenyl GD2 inhibited the binding of mAb 3F8 (5 ng/well) to immo-
bilized GD2 (10 ng/well) in a dose-dependent manner with an IC50 of 10 mM.
Shown is the average and standard error of the mean (SEM) from three inde-
pendent assays. As control, soluble thiophenyl GD3 did not inhibit 3F8-gangli-
oside GD2 interactions; but did inhibit the binding of anti-GD3 mAb R24 to
ganglioside GD3 (data not shown).
Chemistry & Biology
Binding and Bioactivity of GD2 Ganglioside LigandsThen we synthesized three GD2-selective peptidic ligands
that mimic mAb 3F8 using mAb mimicry design (Saragovi
et al., 1992). Their structures and their binding to GD2 micelles
mimicking lipid rafts were studied by NMR. The conformation
of the peptidic GD2 ligands bound to the head group of GD2
was characterized by transferred nuclear Overhauser enhance-
ment (trNOE) experiments that demonstrated their conforma-
tional change on ganglioside binding, and a likely induced-fit
mechanism. The peptides have biological activity similar to the
original ligand mAb 3F8, in cell-based assays of calcium fluxes
and src activation. This report demonstrates that a small-mole-
cule peptide, designed from experimental binding data, can be
a ligand that selectively and functionally interacts with a ganglio-
side sugar head group.
RESULTS AND DISCUSSION
Generation of a Soluble GD2 Analog for Structural
Studies
Ganglioside GD2/3F8 interactions can be inhibited by soluble
thiophenyl GD2 (Figure 1A) in a dose-dependent manner
(Figure 1B). The IC50 of this water-soluble thiophenyl GD2 is
10 mM. Competition is considered to be specific because thio-
phenyl GD3 does not affect the binding of ganglioside GD2 to
3F8. Thus, soluble thiophenyl GD2 can be considered a structural
analog of ganglioside GD2.
Resonance Assignments of Ganglioside GD2 in DPC,
Thiophenyl GD2 and Structure Calculations
The complete proton and carbon chemical shift assignments for
ganglioside GD2 in DPC micelles and thiophenyl GD2 in
aqueous solution are provided in Tables S1 and S2, respectively
(available online). Fifty-one distance restraints, including one
between glucose and the lipid tail ceramide, were obtained
from 2D-ROESY for ganglioside GD2 in DPC micelles. The 2D-
NOESY spectrum that was obtained on thiophenyl GD2 with
a mixing time of 200 ms detected 48 NOEs, which were used
to construct conformations of thiophenyl GD2 (Figure 2). The
root-mean-square deviation (rmsd) within each group of con-
formers was 0.7 A˚ excluding the 2 terminal residues. The
structure of thiophenyl GD2 in water differed from that of
ganglioside GD2 in DPC micelles (rmsd = 3.0 A˚) primarily in
the glycosidic dihedral angles 44f4u4c4 (Figure 1A; Table S3),
which means the terminal neuraminic acid residue can dynami-
cally adopt different conformations in different chemical envi-
ronments. The average value of 42f2 is very similar to those
reported by a molecular dynamics study, indicating that the
conformation of the linkage between galactose and glucose
is not influenced by the presence of other residues in the
ganglioside (Vasudevan and Balaji, 2002). These structures
demonstrated that the ceramide moiety interacted with the
carbohydrate in a way that altered its conformation, which indi-
cates that the conformations of head group and ceramide with
lipid tail are interrelated and influenced by the micelle membrane
(Vasudevan and Balaji, 2001).
The NMR conformers show a well-structured carbohydrate,
which in a 10 ns MD simulation study was stable (data not
shown). Next we studied how this stable structure behaves in
the presence of ligands, such as mAb 3F8.184 Chemistry & Biology 17, 183–194, February 26, 2010 ª2010 ElseGroup EpitopeMapping (GEM): The Binding Interactions
of Thiophenyl GD2 and Ganglioside GD2 with mAb 3F8
STD signals show that the binding of soluble thiophenyl-GD2 to
3F8 can be resolved (Figures 3A and 3B; Figure S2). The most
prominent peaks in the STD spectra arise from the resonancesvier Ltd All rights reserved
Figure 2. Superimposition of GD2 Structures as Determined from Annealing Simulation with Refinement of NMR
(A) Ensemble of thiophenyl GD2 structures (14 conformers).
(B) Ensemble of GD2 ganglioside structures with truncated lipid tails (16 conformers). Glucose = green, galactose = purple, N-acetyl galactosamine = pink. Two
N-acetyl neuraminic acids are in blue (NeuAc (2-3)) and red NeuAc (2-8). For modeling, both ceramide and thiophenyl groups were replaced by a truncated
ceramide (black) with a shorter sphingosine and fatty acid. The reference structure is in CPK representation, and the others are in line representation.
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galactose (Gal). The H3 equatorial (eq) proton of NeuAc (2-3)
experiences the largest STD amplification factor (Figure 3C).
Integral values from the reference and STD spectrum show
that if the largest signal, H3eq, is set to 100% (Tsat = 5 s), the
H2 proton of b-glucose (Glc) and the N-acetyl methyl resonances
reach about 38% and 25%, respectively (Figure 3D). Small
contributions are also observed for protons at 3.8–3.9 ppm
and 3.6–3.7 ppm, which could arise from b-glucose, NeuAc
(2-3), and NeuAc (2-8). However, the signal is not strong enough
to distinguish individual contributions. For the anomeric protons
of glucose and N-acetyl galactosamine (GalNAc), no obvious
STD response was observed, which may be due to their close
proximity to the HDO resonance.
The intensities of the observed STDs are primarily dependent
upon the longitudinal relaxation rate of the free ligand proton at
long saturation times (Yan et al., 2003). This is seen at the long
saturation times (1–5 s) employed in our experiments (Table
S4). The methyl groups and Glc/Gal H2 protons have the longest
T1s, and in the STD spectra give more significant signals than
other sugar protons falling between 3.6 and 3.9 ppm.
The proton of NeuAc (2-3) H3 eq, which has a short T1
(0.7 s), showed the largest amplification factor at different
saturation times (data not shown). This indicates that the
side of sugar rings with the N-acetyl group and carboxylic
acid is directed toward the antibody. Additional STD experi-
ments with increasing concentrations of thiophenyl-GD2 shows
that a maximum amplification is reached for the more weakly
interacting protons at 1 mM (Figure 3C). The more strongly inter-
acting proton did not reach maximum amplification under the
experimental conditions. Any possible nonspecific contribution
to this binding cannot be excluded at this time (Ji et al., 2009),Chemistry & Biology 17, 183because there is no high-affinity inhibitor to saturate the specific
binding site.
The STD NMR profile of ganglioside GD2 embedded in DPC
micelles showed that the water-exposed sugar head groups
could also interact with the antibody. The STD spectrum of
GD2 ganglioside in DPC micelles interacting with mAb 3F8
showed that additional peaks of sugar and ceramide are
observed at 3.8–3.9 ppm, the peaks from the acetyl methyl reso-
nances are enhanced, and a new DPC peak at 3.28 ppm appears
(Figure S2).
The control STD spectrum of GD2 ganglioside in DPC micelles
with no mAb 3F8 shows signals arising from the methyl groups of
neuraminic acid and N-acetyl galactose, and from DPC, caused
by irradiation of the DPC micelle or by nonspecific interaction of
these methyl groups with the DPC micelle.
To confirm whether signals in the STD spectrum in the pres-
ence of mAb 3F8 arise from saturation transfer from the mAb,
the on-resonance saturation frequency was shifted from 2 to
9 ppm. This resulted in a very similar STD spectrum, indicating
that the GD2 head group did interact with mAb 3F8 in this
membrane-like environment. The low signal to noise in the STD
spectra of the GD2/mAb spectra made it difficult to obtain defin-
itive binding epitope information, however it is clear that some
parts of the carbohydrate are more important than others for
the binding interaction.
Next, we further studied the interaction by computer docking,
to determine whether conformational changes occur in the
complex.
Docking Studies of GD2 with mAb 3F8
In the absence of a crystal structure for mAb 3F8, a model was
generated for the binding of GD2 in the antigen-binding site of–194, February 26, 2010 ª2010 Elsevier Ltd All rights reserved 185
Figure 3. STD NMR Spectra, STD Amplification Factor, and Structure Model of Thiophenyl GD2 Binding to mAb 3F8
(A) Reference spectrum of a mixture of thiophenyl GD2 (500 mM) and 3F8 (10 mM binding sites) at a 50:1 ratio.
(B) STD-NMR spectrum of the same sample (Tsat = 5 s).
(C) Observed STD amplification factors of several resonances of thiophenyl GD2 plotted against the ligand concentrations (Tsat = 3 s).
(D) The most prominent peaks in the STD spectra arise from the resonances of the residue NeuAc (2-3) in green. Atoms in red correspond to the strongest STD
signal, which is assigned a value 100%. Magenta coloring corresponds to residues that are about 20%–40% saturated.
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Intermolecular interactions (both electrostatic and hydrophobic)
were observed between the GD2 molecule and 3F8 (Figure 4). At
the antigen-binding surface, GD2 interacts mainly with residues
of light-chain 3 (L3), heavy-chain 2 and 3 (H2 and H3) of comple-186 Chemistry & Biology 17, 183–194, February 26, 2010 ª2010 Elsementarity determining region (CDR), as well as with framework
residues.
Both the glucose and galactose residues of GD2 bound in the
shallow groove in mAb 3F8 between the variable domain light
(VL) and variable domain heavy (VH) chains and interact withvier Ltd All rights reserved
Figure 4. The Predicted Binding Mode of GD2 in the Antigen Binding Surface of a Fab Fragment of 3F8 Antibody
(A) The Fab fragment is displayed as a molecular surface. Color coding is as follows: VL (cyan), VH (green), L1 (red), L2 (blue), L3 (orange), H1 (red), H2 (blue), and
H3 (orange). GD2 is depicted as capped sticks with carbon, nitrogen, and oxygen in yellow, blue, and red, respectively.
(B) The Fab of 3F8 VL and VH is displayed as a ribbon structure. Selected residues of 3F8 are represented as thick-capped sticks with carbon, nitrogen, and
oxygen in pink, blue, and red, respectively. GD2 is shown as capped sticks, color coded as in (A). Significant nonpolar interactions with GD2 are observed
for Ile2 (framework), Tyr 92 (L3), Ile 165, Met 173 (H2), and Tyr 211 (H3). Electrostatic interactions with the GD2 molecule are observed for Ser1 (framework),
Thr 166, Asn 167, and Ser170 (H2).
(C) Detailed view of polar interactions between the 3F8 antibody and the GD2 molecule. The Fab of 3F8 VL and VH is displayed as a ribbon structure. Selected
residues of 3F8 are represented as thick-capped sticks with carbon, nitrogen, and oxygen in gray, blue, and red, respectively. GD2 is shown as capped sticks,
color coded as in (A). Black dashed lines are H-bonds. Distances are measured between the heavy atoms. Ser1 (framework), Thr 166, Asn 167, and Ser170 (H2)
form H-bonds with the GD2 molecule.
(D) Hydrophobic interactions between GD2 with the residues of 3F8. These residues are Ile2 (framework), Tyr 92 (L3), Ile 165, Met 173 (H2), and Tyr 211 (H3) are
represented as thick-capped sticks with the carbon, nitrogen, oxygen, and hydrogen atoms in pink, blue, red, and white, respectively. Distances are measured
between hydrogen atoms.
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the lower part of the groove and the N-acetyl group makes good
hydrophobic interactions with framework residue Ile2. Both
NeuAcs bind into a relatively flat area of the antigen-binding
surface formed mainly by the residues of the H2 CDR and few
residues of the H3 CDR (Figures 4A and 4B). Four residues in
the antigen binding site hydrogen bond with the GD2 moleculeChemistry & Biology 17, 183(Figure 4C). The middle NeuAc shows hydrogen-bond interac-
tions with Ser170 on the H2 CDR, whereas the terminal one is
largely solvent exposed. The hydroxyl group on the seventh
carbon of the terminal NeuAc forms a hydrogen bond with the
H2 CDR of 3F8 by way of the backbone carbonyl of Thr166
and the side chain of Asn167. The N-acetyl groups of both
Neu5Ac residues make nonpolar contacts with Tyr211, Ile165,–194, February 26, 2010 ª2010 Elsevier Ltd All rights reserved 187
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3F8 and GD2 complex was 8.2 kcal/mol (Ki = 0.95 mM).
The bound conformation of GD2 in our docking model is
different from the unbound one determined by NMR (rmsd =
3.0 A˚ excluding the 2 terminal residues). The GD2/3F8 binding
model showed that both NeuNAcs bound into a relatively flat and
shallow surface area formed mainly by the residues of H2 CDR
loop and a few residues of the H3 CDR loop (Figures 4A and
4B). This may explain why the middle NeuAc (2-3), instead of
the terminal one, is the most prominent residue interacting with
3F8 (Figures 3A and 3B).
In order to validate the docking binding model, the theoretical
STD effect upon some protons was calculated with the
CORCEMA-ST program at different saturation times (Table S4;
Experimental Procedures). Taking into account an estimated
experimental error of 10%–20% for the STD data, the R-factor
(0.42) is indicative of a reasonable fit between the experimental
and calculated values. Hence, our binding model is compatible
with the experimental STD data.
Together, the STD-NMR epitope mapping of thiophenyl GD2
and ganglioside GD2 with mAb 3F8 and the docking studies of
GD2 with 3F8 are consistent, and provide a starting point for
designing small molecule ligands of GD2.
Design of Peptidic Ligands
Further support for the predicted region of mAb 3F8 that binds to
GD2 comes from the fact that peptide ligands could be designed
from this region to mimic the antibody binding surface and yield
peptides that interact with GD2 micelles. Small peptidic GD2
ligands M1, M50, and SS58 were designed based on models
of the monoclonal antibody 3F8/GD2 complex, mainly mimicking
the H2 CDR that curiously also corresponds to a sequence in
Tenascin-R (accession number NP_003276), which is reported
to be a putative GD2 ligand (Probstmeier et al., 1999). A compar-
ison of anti-GD2 mAbs and TN-R sequences showed high
sequence homology between the mAb CDRs and the N-terminal
portion of TN-R, which is thought to be the GD2-binding site. It is
intriguing that this sequence, ASN-TYR-ASN, is very restricted in
the mammalian genome and appears in very few proteins.
Core sequences were flanked by cysteine residues, which,
once oxidized, form an intramolecular S-S bond forcing the
peptides to adopt the cyclic, b-turn-like conformation seen in
CDRs. All peptides were synthesized and tested as control linear
analogs devoid of terminal cysteines, to verify the effect of struc-
ture on binding. In addition, several control cyclic peptides of
related sequences were inactive. To validate the docking binding
model and investigate how these peptide ligands bind to GD2,
their interactions were studied by NMR and in vitro assays.
Assignments of Peptide Ligand Resonances
and Structure Calculations
The sequences and complete proton chemical shift assignments
for the 11-residue peptides M50 and SS58 and the 10-residue
peptide M1 are provided in Tables S5 and S6. Three-dimensional
structures were calculated for M50 and M1 from NMR data. The
conformations of these two peptides are relatively flexible in
the free state (Table S7). The data show that a random coil is
the main secondary structure for M50 (Figure 6) and for M1
(Figure S3), with a b-turn as a minor conformation.188 Chemistry & Biology 17, 183–194, February 26, 2010 ª2010 ElseGroup EpitopeMapping (GEM): The Binding Interactions
of Peptide Ligands M50, M1, and SS58 with GD2
Micelles
The ganglioside GD2 concentration (200 mM) in STD-NMR
experiments exceeded the reported critical micelle concentra-
tion (CMC) (Sonnino et al., 1994), and 1D-1H NMR spectra
showed that it formed micelles in water (data not shown).
The STD spectrum indicates that the M50 peptide ligand
binds to ganglioside GD2 micelles (Figures 5A and 5B). All
of the protons in the M50 peptide experienced some degree
of saturation on binding to GD2. Calculation of the STD effects
for each resolved proton signal indicated that the tyrosines
and Ile4 made the most important contacts with GD2. The
aromatic resonances of Tyr1, 6, and 11 could not be resolved
to itemize individual effects; however, the overlapping multiplet
structure was very similar in the reference and STD spectra,
indicating that each aromatic ring contributed equally to the
intensity.
STD experiments were recorded at saturation times varying
from 1 to 5 s for a 5-fold ligand excess, demonstrating that the
maximal amplification factor is reached by 3 s of saturation for
residues with weaker interactions such as alanine (Figure 5C).
The T1s for the resolved protons in the free peptide were
measured using an inversion-recovery pulse sequence, and indi-
cated that at longer relaxation times (>2 s) the STD intensities
were dominated by T1 effects. Protons with the longest T1s,
such as those in the tyrosine aromatic rings, display the largest
STD effect. The initial slope of this plot gives a more accurate
reflection of the binding epitope (Yan et al., 2003). Although
very short (<1 s) saturation times were not employed in this
study, the relevance of tyrosines and isoleucine is indicated
from their steeper initial slope in comparison with the resolved
glycine or alanine protons. A series of STD titration experiments
delivered STD amplifications as a function of ligand excess
(Figure 5D). This shows that the maximal effect was not reached
under the experimental conditions, which were limited by the
necessity to maintain a minimum concentration of GD2 ganglio-
side to ensure micelle formation.
The interactions of two other peptide ligands (M1 and SS58)
with ganglioside GD2 micelles were also investigated by STD
experiments (see Figure S4 for STD NMR spectra). STD signals
of M1 and SS58 show that the ligands bind to the GD2 micelles.
As was observed for M50 (Figure 5), the tyrosines and the
methyl resonances of threonine and isoleucine gave the largest
STD effects, suggesting that the protein-glycan interactions
are dominated by hydrophobic side chains of methyl groups
and aromatic rings.
In order to study the conformation of bound ligand, and to
complement the STD NMR results, NOESY experiments were
recorded for a mixture of M50 and GD2 ganglioside micelles.
Many more cross-peaks were observed in the NOESY spectrum
of the mixture in comparison to NOESY or ROESY spectra of the
free peptide (Figure 6A). For instance, several cross-peaks
between Ha and amide (Gly3 -Ala5, Ile4-Asn6, Ile4-Tyr7, Ala5-
Tyr7 and Gly9-Try11) were observed. These transferred NOEs
showed that the major conformation of the ligand becomes
a b-turn (‘‘W’’ shape) in the bound state as compared with
a more flexible b-coil (‘‘U’’ shape) in the free state (Figures 6B
and 6C; Table S7).vier Ltd All rights reserved
Figure 5. STD-NMR Spectra and STD Amplification Factor for a Mixture of Ganglioside GD2 Micelles and M50B
(A) Reference spectrum of a mixture of ganglioside GD2 micelles (200 mM) and peptide ligand M50B (1 mM) in a ratio of 1:5.
(B) STD-NMR spectrum of the same sample at 298 K (Tsat = 5 s).
(C) Observed STD amplification factors of several resonances of peptide ligand M50B plotted against the saturation time in a ratio of 1:5 (ligand excess).
(D) Observed STD amplification factors of several resonances of thiophenyl-GD2 plotted against the ligand concentrations (Tsat = 5 s).
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software DSSP (Kabsch and Sander 1983) shows that in the
bound state there are multiple b-turns with three hydrogenChemistry & Biology 17, 183bonds formed, while no hydrogen bonded turns exist in the
free state. In the bound state the turns are formed by Cys2 to
Ala5, Asn6 to Gly9, and Cys2 to Asn6. In contrast, in the free–194, February 26, 2010 ª2010 Elsevier Ltd All rights reserved 189
Figure 6. Ensemble of 12 and 19 Lowest-Energy Structures Calculated for the M50B in the Free and Bound State in Water, Respectively
(A) Overlay of ROESY spectrum (black) of M50B in the free state and trans-NOESY spectrum (red) of M50B in the bound state. The mixing times used to record
these spectra are 200 and 100 ms, respectively.
(B) The ensembles of structures are in flat ribbon representation and the b turn is in green.
(C) The average structure is in line representation (water molecules are removed). The disulfide bond is in yellow. Three hydrogen bonds between carbonyl group
and amide of Cys2 and Ala5, Cys2 and Asn6, and Asn6 and Gly9 are in green.
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b-coil (Figure 6B). The rmsd between these different states is
2.7 A˚ (calculated for residues 2 to 10).
It appears that the STD spectra were influenced by T1 effects
at the longer saturation times used in this study; however, the
trNOE results for the peptide show that it adopts a conformation
in the presence of GD2 where aromatic and Ile residue side
chains are on the same face of the molecule, directed
toward the carbohydrate. Although transferred NOE data were
not obtained for the other peptidic ligands M1 and SS58, we
anticipate that they might also form a similar b-turn upon binding
to GD2 because of their high degree of sequence homology
to M50.
Together, these data suggest an induced-fit model in which
cyclic peptidic ligands adopt a new b-turn conformation upon
interacting with GD2. Such b-turn conformation resembles those
adopted by antibody CDRs (Saragovi et al., 1992).
Assessment of Ligand Interactions with Gangliosides
by Competitive ELISA
The binding specificity of M50, M1, and SS58 was evaluated
by competitive ELISA using immobilized gangliosides GD2,
GD3, or GM1.
M1 inhibits the binding of mAb 3F8 to GD2 in a dose-
dependent manner, with an IC50 between 100 and 200 mM.190 Chemistry & Biology 17, 183–194, February 26, 2010 ª2010 ElseM50 inhibits binding of mAb 3F8 to GD2 by 66% at 200 mM
(Figure 7A).
SS58 inhibits the binding of mAb 3F8 to GD2 by 50% at
350 mM. In control assays, SS58 does not prevent cholera toxin
B from binding GM1. The peptide also shows weak inhibition of
anti-GD3 antibody binding to GD3 (Figure 7B). Thus, the SS58
peptide has excellent selectivity for GD2 over GM1, and good
selectivity for GD2 over GD3.
It is possible that SS58 binds to both GD2 and GD3. Whether
or not SS58 binds specifically to GD3 is a difficult issue to resolve
because the peptide has lower affinity and lower avidity than
3F8. Also, the peptide represents only a selected part of the
pharmacophore of 3F8 and some of the 3F8 specificity may
have been compromised. GD2 and GD3 have very similar
chemical structures, the only difference being that GD2 has an
N-acetyl-galactose connecting to the galactose (Figure S2).
For these three reasons, especially the closeness of the epitopes
of GD2 and GD3, it is not surprising that the peptide could bind to
GD3 with low efficacy in the enzyme-linked immunosorbent
assay (ELISA) competition assays.
More than 50 control peptides were tested in parallel,
including linear analogs of the active cyclic peptides, and several
inactive cyclic peptides of related sequences. For example,
control peptide 57 (a linear and unstructured analog, see Exper-
imental Procedures) did not block GD2-3F8 interactions (datavier Ltd All rights reserved
Figure 7. Peptide Ligands M1, M50 and SS58 Selectively Bind to
Ganglioside GD2
(A) Binding of peptides M1 and M50 to GD2 was evaluated by their ability to
compete anti-GD2 mAb 3F8 binding to immobilized GD2. M1 and M50
strongly inhibit GD2/3F8 interaction. Shown are the averages ± SEM of four
to six independent assays, n = 3 per assay.
(B) The selective binding of peptide SS58 to GD2 ganglioside was evaluated by
its ability to compete anti-GD2 mAb 3F8, but not anti-GD3 mAb MB3.6 binding
Chemistry & Biology
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Chemistry & Biology 17, 183not shown), suggesting that a constraint to induce a b-turn is
required; and cyclic peptide NB1.HC1.7 (YCTNYGVCY) derived
from a different domain of 3F8 did not inhibit the binding in the
ELISA.
Overall the data are consistent with the binding detected by
NMR, and with the interpretation that the peptide ligands bind
the carbohydrate of GD2.
Functional Mimicry of mAb 3F8
Binding of ganglioside ligands (such as antibodies) to cell
surface gangliosides induces Ca2+ fluxes (Gouy et al., 1994;
Golard, 1998) measurable by the calcium-sensitive fluorophore
Rhod-2 AM. The Ca2+ fluxes involve the activation of the src
family kinases (Hakomori and Zhang, 1997; Golard, 1998; Birkle
et al., 2003).
We studied intracellular Ca2+ levels and activation of the src
family kinase p56LCK in the EL4 thymoma cell line, which
expresses GD2 and GM1, but does not express GD3 on the
plasma membrane. Exposure of EL4 cells to positive control
mAb 3F8 (13 nM) increased intracellular Ca2+. Negative controls
(untreated cells or cells treated with nonbinding mouse IgG)
do not affect Ca2+ levels, and the positive control ionophore
increases intracellular Ca2+ levels rapidly. This is consistent
with the literature (Golard, 1998). Test treatment with SS58 (20
mM) strongly increases the intracellular Ca2+, although the effect
is slower than that of mAb 3F8 (Figure 7C). The increased intra-
cellular Ca2+ caused by both mAb 3F8 and SS58 can be blocked
by the src inhibitor PP1 (data not shown).
In biochemical assays, exposure of EL4 cells to positive
control mAb 3F8 or to test SS58 peptide reduced the phosphor-
ylated state of p56LCK-pTyr505. The negative control linear
analog SS57 does not induce p56LCK-pTyr505 de-phosphoryla-
tion, whereas the positive control phosphatase inhibitor H2O2
increases the phosphorylated state of p56LCK-pTyr505 (Fig-
ure 7D). These results are consistent with the above studies of
Ca2+ fluxes. The p56LCK-pTyr505 is an inhibitory phosphotyro-
sine, and its dephosphorylation is required for activation of the
kinase enzymatic activity of p56LCK, leading to Ca2+ fluxes
(Palacios and Weiss, 2004). In further control assays, treatment
of a GD2-negative subclone of EL4 cells with peptide SS58 did
not activate p56Lck, even though these cells express the same
levels of p56Lck as the parental GD2 cells (data not shown).
Together the data show that functionally these small peptidic
ligands of GD2 activate signaling pathways in live cells in
a manner similar to mAb 3F8.to immobilized GD3, or cholera toxin B binding to immobilized GM1. Shown
are averages ± SEM of two independent assays, n = 4 per assay.
(C) Peptide SS58 increases intracellular calcium. Live EL4 cells (expressing
GD2 and GM1) were treated with mAb 3F8 (13 nM), control mouse IgG
(mIg), peptide SS58 (20 mM), the GM1 ligand CTB, or the calcium ionophore
A23187; and intracellular calcium concentrations were evaluated over time
by flow cytometry using the calcium-sensitive fluorophore Rhod-2 AM. Shown
are averages of four independent assays ± SEM.
(D) EL4 cells were treated with control mIgG (13 nM, lane 1), hydrogen peroxide
(H2O2, 20 mM, lane 2), anti-GD2 mAb 3F8 (13 nM, lane 3), or peptides SS58
(3.3 mM, lane 4) or peptide SS57 (3.3 mM, lane 5) for 20 min at 37C. The
p56Lck immunoprecipitated samples were probed for Tyr505 p56Lck using
a specific anti-pY505 antibody. The blot shown is representative of four inde-
pendent experiments.
–194, February 26, 2010 ª2010 Elsevier Ltd All rights reserved 191
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In this study, the combined use of STD-NMR spectroscopy,
transferred NOE experiments, and molecular modeling
furnished details on the molecular recognition of the gangli-
oside GD2 by the monoclonal antibody 3F8; specifically, it
furnished details of conformational changes in the antibody
CDR loops. Moreover, similar NMR experiments were per-
formed on complexes between GD2 and three small peptide
ligands, which were designed using the structural informa-
tion and which were validated in binding and functional
studies.
The present work reveals the key pharmacophoric groups
that are required for the recognition of the cell-surface
carbohydrate epitope recognized by the mAb 3F8 and
suggests an induced-fit mechanism through which unstruc-
tured antibody CDRsmay adopt a b-turn conformation upon
interacting with GD2.
Our work furthers the concept that it is possible to
develop small-molecule ligands of highly flexible targets
such as ganglioside carbohydrates, and rationalizes that
gangliosides may be druggable targets. The structural infor-
mation gleaned from studying the protein- and peptide-
carbohydrate interactions has enhanced understanding of
ganglioside-ligand interactions and may facilitate design
of improvedGD2 ligands, and ligands for other gangliosides.
EXPERIMENTAL PROCEDURES
Synthesis of Thiophenyl GD2
Thiophenyl GD3 was synthesized from thiophenyl Lac as described previously
(Houliston et al., 2007). Thiophenyl GD2 (Figure 1A) was synthesized from
thiophenyl GD3 using a recombinant b-1,4-N-acetylgalactosaminyltransferase
(CgtA, construct CJL-30) and an UDP-GlcNAc 4-epimerase (Gne, construct
CPG-13) originally cloned from Campylobacter jejuni (Bernatchez et al.,
2005; Blixt et al., 2005). The sample was purified (>98%) by high-performance
liquid chromatography (HPLC) (Waters 600) using a C-18 semipreparative
column (Phenomenex), and was verified by electrospray ionization mass
spectrometry and NMR. The measured molecular weight of thiophenyl GD2
corresponded to expected values.
Peptide Ligand Synthesis
Peptides were designed based on the structures of mAb 3F8 and Tenascin-R.
Peptide ss58 is YCGGIANYNCY, peptide M1 is YCGTNYNGCY, and peptide
M50 is YCGIANYNGCY. Peptide SS57 is a linear analog that can not cyclize,
with sequence GGIANYNTS. Peptides were synthesized with an Advanced
Chemtech automatic synthesizer using solid-phase Fmoc chemistry. After
cleavage from resin and side-chain deprotection, peptides were subjected
to cyclization by oxidation (which caused disulfide-bond formation) at 4C
under O2 in 50 mM ammonium bicarbonate (pH 8.5). Cyclic peptides were
repurified (>95%) by HPLC (Varian) using a C-18 preparative column (Phenom-
enex), and were characterized by mass spectrometry and NMR spectroscopy.
The measured molecular weight of linear and cyclic peptides corresponded to
expected values.
Quantification of Thiophenyl GD2–3F8 mAb Interactions
by Competitive ELISA
Gangliosides GD2 or GD3 (Advanced ImmunoChemical Inc.) (10 ng/well, in
ethanol) were immobilized onto polystyrene Corning Strip Well 96-well plates
(Fisher Scientific) by evaporation in a fume hood for 2 hr. The wells were
then filled with phosphate-buffered saline containing 0.5% bovine serum
albumin (PBS-0.5% BSA) for 1 hr. In competition assays, increasing concen-
trations of soluble ganglioside, dissolved in PBS, were added to the plates
for 30 min before adding the mAbs. Then, anti-GD2 monoclonal antibody192 Chemistry & Biology 17, 183–194, February 26, 2010 ª2010 Else3F8 (5 ng/well) (prepared and characterized in house [Cheung et al., 1985])
or anti-GD3 monoclonal antibody R24 (15 ng/well) (Abcam) was added for
15 min. The plates were washed three times with PBS-0.5% BSA and incu-
bated 20 min with 1/1000 dilution of horseradish peroxidase-conjugated
anti-mouse antibody (Sigma). After three washes with PBS-0.5% BSA and
two with PBS, the colorimetric substrate TMB One Solution (Promega) was
added, and the reaction stopped with 0.5 N H2SO4 and the plates were read
at 450 nm (Benchmark Plus, Bio-Rad). Wells with no mAb added were treated
as background and standardized as 0% binding. Wells with no competitor
ganglioside added were standardized as 100% binding.
NMR Spectroscopy
All NMR experiments were carried out on a 500 MHz Varian INOVA NMR spec-
trometer equipped with a triple-resonance H {CN} cold probe and z-axis
pulsed field gradients. 2D NMR spectra were processed by NMRPipe (Delaglio
et al., 1995) and assigned by SPARKY 3 (T. D. Goddard and D. G. Kneller,
University of California, San Francisco).
NMR Spectroscopy of Ganglioside GD2 and Thiophenyl GD2
Mixed micelles were prepared by dissolving ganglioside GD2 (1 mM) and the
detergent dodecylphosphocholine-d38 (DPC, molar ratio 1:40) in deuterated
50 mM phosphate buffer (pD 6.6) (Acquotti et al., 1990). Thiophenyl GD2
was dissolved in deuterated 50 mM phosphate buffer. Spectra were obtained
at 308 K or 298 K, respectively. 1H-1H gradient-selected COSY spectra, DQF-
COSY, TOCSY, ROESY with 200 ms, NOESY spectra with mixing times of
50–200 ms, 13C HMBC, and HSQC spectra were recorded. 1H chemical shifts
were referred to an internal sodium 2,2-dimethyl-2-silapentane-5-sulfonate
standard at 0.00 ppm. 13C chemical shifts were indirectly referenced to the
proton frequency (see additional details in the Supplemental Experimental
Procedures).
NMR Spectroscopy of Peptide Ligands
Samples contained M1, M50, or SS58 in 10% D2O/90% H2O (v/v) or
100% D2O at pH 6.0 or 3.0, at 298 K. Standard experimental protocols were
used for TOCSY, phase-sensitive double quantum filtered-COSY, COSY-30,
NOESY, and ROESY spectra.
STD-NMR Spectroscopy
A 1D saturation transfer difference pulse sequence with internal subtraction via
phase cycling was employed to record difference spectra (Mayer and Meyer,
2001). On-resonance irradiation of GD2 gangliosides and mAb 3F8 was
performed at 0 ppm, except in the case of GD2-DPC micelles, where on reso-
nance irradiation of the antibody was at 2 ppm. Off-resonance irradiation
was at 34.8 ppm. Reference spectra were recorded using the same pulse
sequence with saturation pulses applied at 34.8 ppm, and no internal subtrac-
tion. Experiments were recorded with saturation times of 5 s, 3 s, 2 s, and 1 s.
Spectra were recorded with 32000 points, a sweep width of 16 ppm, and 1024
to 2048 transients (see additional details in the Supplemental Experimental
Procedures). STD spectra were processed by MestReNova-Lite v5.2.1-3586
(Mestrelab Research SL). To test the shaped pulse selectivity, STD experi-
ments on thiophenyl-GD2, M50B, M1, and GD2 in DPC micelles alone without
antibody were acquired. No ligand signals were present in the STD spectra
for thiophenyl-GD2, M50B, and M1. However, there is a nonspecific signal
of methyl groups for GD2 in DPC micelles. Inversion-recovery experiments
to measure longitudinal relaxation times (T1) for free thiophenyl-GD2 and
M50 were acquired. For the titration and saturation experiments, we used
the STD amplification factor (Mayer and Meyer, 2001) for a better assessment
of the absolute magnitude of the STD effect. After the STD-NMR experiments,
transient transferred NOE experiments employing different mixing times were
performed.
Sample Preparation for Thiophenyl GD2 and mAb 3F8/Ganglioside
GD2 in DPC and mAb 3F8 Interactions
3F8 was concentrated using Amicon centrifugal filters (10 kDa cutoff, Millipore)
and exchanged several times with a deuterated 50 mM phosphate buffer
(pH 6.0). The mAb preparations were combined with freeze-dried thiophenyl
GD2 or ganglioside GD2 in DPC (CDN Isotopes) micelles at molar ratios
ranging from 1:25 to 1:200; the final oligosaccharide concentrations werevier Ltd All rights reserved
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absence of binding partner to confirm that the ligand was not excited by the
saturation pulses at 0 ppm.
Sample Preparation for Peptide Ligands Bound to Ganglioside GD2
Micelles
The ganglioside GD2 was subjected to three cycles of freeze-drying with D2O
to remove traces of water and to prepare a stock solution with a final concen-
tration of 3 mM in deuterated 50 mM phosphate buffer (pH 6.2). Dilution effects
from addition of this GD2 stock solution to peptide ligands solution to make
different ratios were minimal. Stock solutions of peptide ligands, 2 to 3 mM
each, were prepared by dissolving them in deuterated 50 mM phosphate
buffer. The concentrations of the peptides were determined by UV (Nano-
drop 1000, Wilmington) at 280 nM. 1D STD-NMR spectra were acquired at
298 K for a variety of peptide to GD2 ratios.
Structure Calculations
Different mixing times of NOESY spectra were used to evaluate the linear
build-up of NOEs. Molecular dynamics simulations with NMR refinement in
the AMBER 9 GB Model (Case et al., 2005) with the force field (Glycam_04.dat
[Woods et al., 1995] and GAFF [Wang et al., 2004]) were employed to deter-
mine the energetically favorable conformations of the two types of unbound
ganglioside. The topology file of truncated ceramide was produced by
ANTECHAMBER (Wang et al., 2006). 3D structures of peptide ligands were
calculated by the software ARIA 2.2/CNS 1.2 with the network anchoring
approach (Rieping et al., 2007). From the 200 structures calculated for each
peptide, the 20 lowest energy ones were chosen and clustered by MMTSB
(Feig et al., 2004). Structures were visualized using Discovery Studio 1.7
(Accelrys), PyMOL, and VMD-Xplor on Mac OS X (see additional details in
the Supplemental Experimental Procedures).
Docking Studies
Structure Prediction, Model Building, and Refinement
The crystal structure of malaria antigen AMA1 antibody Fab (Protein Data Bank
[PDB] code 2q8a) (Coley et al., 2006) and 13G5 antibody Fab (PDB code 2gjz)
(Muller et al., 2007) were selected as templates for the light chain (84%) and
heavy chain (84%) of 3F8, respectively. The homology modeling was carried
out using the program COMPOSER in SYBYL 7.3 (Tripos). Structural refine-
ment of the complex was done by stepwise energy minimization in Sybyl using
the AMBER all-atom force field to a gradient of 0.05 kcal/mol/A˚. This energy-
minimized model was then used as starting point for MD simulation in explicit
water, using the AMBER ff03 force field in the AMBER 9. The MD average
structure was obtained from the most stable part of the trajectory for docking
study (see additional details in Supplemental Experimental Procedures and
Figures S5 and S6).
Molecular Docking of GD2 and CORCEMA-ST Calculations
The GD2 docking in the putative binding site of Fab fragment of 3F8 was per-
formed with in-house docking software (S.C. and E.O.P., unpublished data).
A box around the 6 CDRs of the heavy and light chain of 3F8 was constructed
and defined the binding region to be searched. In order to sample various
conformations, 12,000 conformers of GD2 were generated from snapshots
taken from an MD simulation (12 ns) in explicit water using AMBER ff03 and
GAFF force fields starting from the NMR structures. Partial charges of the
conformers were calculated by the AM1-BCC method (Jakalian et al., 2002).
Each of the docked conformers of GD2 was exhaustively docked into the
3F8 Fab and scored. The top-scoring 100 poses were clustered. The most
populated cluster was taken to be representative of the true GD2 binding
mode in the Fab of 3F8 antibody. The best-scored pose from this cluster
was selected to represent the binding model. This pose was subjected to mini-
mization followed by a 5 ns MD simulation. The MD trajectory was used to
calculate a predicted binding free energy of the complex using a solvated inter-
action energy (SIE) approach (Naim et al., 2007). Then, CORCEMA-ST (Jaya-
lakshmi and Krishna, 2002) program was used to calculate theoretical STD
effects (see additional details in Supplemental Experimental Procedures).
Detection of Peptide-Ganglioside Interaction by Competitive ELISA
ELISAs were as described above, except that cyclic or linear peptides (50 mg/
well, in PBS) were added to the wells as putative competitors for 1 hr before
anti-ganglioside antibodies or anti-GM1 cholera toxin-B (CTB). Selectivity ofChemistry & Biology 17, 183competitive inhibition of GD2-3F8 interactions was determined by monitoring
the effect upon GM1-CTB and GD3-anti-GD3 interactions. Wells with no
peptide added or control irrelevant peptide added were standardized as
100% binding. Wells with no 3F8 added and also wells where 3F8 was
replaced with mouse IgG were standardized as 0% binding.
Intracellular Calcium Studies
GD2-expressing EL4 thymoma cells (1 3 106 per sample) were washed with
Ringer’s solution (155 mM NaCl, 4.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2,
10 mM D-glucose, 5 mM HEPES) and resuspended in 1 ml Ringer’s for
15 min at 37C. Then 5 mM Rhod-2AM (Molecular Probes) was added to the
cells and incubated for 30 min at room temperature with mild agitation. Cells
were washed, and resuspended in 1 ml Ringer’s, and incubated for 30 min,
after which cells were stimulated with the indicated ganglioside ligands
(or calcium ionophore A23187 as control) and analyzed over a 30 min period
for intracellular Ca2+ using a flow cytometer (Becton Dickinson).
Ex Vivo T Cell Receptor Activation
EL4 thymoma cells (5 3 106 per sample) in culture media were treated with
control mouse IgG (13 nM), mAb 3F8 (13 nM), peptides 57 and 58 (3.3 mM),
or hydrogen peroxide (20 mM) for 20 min at 37C. After lysis in mild lysis
buffer (10 mM CHAPS, 0.15 M NaCl, 0.01 M sodium phosphate [pH 7.2],
2 mM EDTA, 50 mM sodium fluoride, EDTA-free protease inhibitor cocktail
[Roche]), p56Lck protein was immunoprecipitated with protein A-agarose
beads (Upstate Biotechnology) coated with anti-p56Lck mAb 3A5 (Santa
Cruz) and samples were probed in western blots for Tyr505 p56Lck using rabbit
anti-PY505 antibody (Abcam).
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